Blog: Barry Callebaut scores win with EFSA health claim backing
Michelle Russell | 19 July 2012
Swiss B2B chocolate manufacturer Barry Callebaut has scored a significant win this week after securing backing from the European Food Safety Authority (EFSA) on a health claim linking cocoa to improved blood flow.
The company had submitted the claim last year, along with evidence that 200mg of cocoa flavanols (compounds that can also be found in dark chocolate) per day helps maintain "endothelium-dependent vasodilation which contributes to normal blood flow".
Barry Callebaut claims to be the first company in the 27-member bloc to obtain an official and positive scientific opinion of the positive effects of cocoa flavanols.
Securing the back of the European food agency is a significant development for both the company and its customers who use high-flavanol cocoa products to make the claim on their products and packaging.
Winning such a claim could give Barry Callebaut a serious competitive advantage. As the company says, it sees "new market potential", including for applications in chocolate drinks, cereal bars and biscuits.
The company is still awaiting approval from the EU Commission for its health claim, which would give it the right to use the cocoa flavanols claim for five years within EU countries. A final decision is expected in early 2013.
Today (23 December) is just-food's last day before closing for Christmas. We'll return, raring to go on Tuesday 3 January - but of course there's been plenty of top-notch content that has gone live in...
- Comment: Premier has more to ponder than Brexit
- Trump seen as negative for global food trade
- 2017: food policy hotspots in the UK, EU and US
- Analysis: B&G Foods balancing growth and decline
- Why near-term takeover of Mead Johnson unlikely
- Weetabix takeover talk gathers pace
- Unilever rebrands I Can't Believe It's Not Butter
- Boparan confirms interest in Fox's Biscuits
- Nestle mum on Mead Johnson takeover talk
- Update - Pladis not bidding for Weetabix